Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06008769 · ClinicalTrials.gov registry record · NA

Therapy for People With Opioid Use Disorder

A NA study of Opioid Use Disorder, sponsored by Philadelphia College of Osteopathic Medicine.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06008769 is a NA study of Opioid Use Disorder that is active but no longer recruiting, run by Philadelphia College of Osteopathic Medicine. The registered enrollment target is 20 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06008769, a NA study of Opioid Use Disorder, is active but no longer recruiting, sponsored by Philadelphia College of Osteopathic Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot clinical trial is to test the feasibility of a 12-week manualized cognitive-behavioral therapy treatment for opioid use disorder in reducing or stopping illicit opioid use in a community setting. Participants will complete 12 weeks of therapy with a behavioral health counselor and will complete assessments at baseline and 12 weeks. Other outcomes include changes in mood and perceptions of recovery-related support after 12 weeks of therapy.

Conditions Studied

Interventions

  • BEHAVIORAL 12 Week Manualized Cognitive-Behavioral Therapy Intervention

Study Locations (1)

Pennsylvania

  • Prevention Point Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-08-06
Est. Completion 2024-08
Phase NA

What the Registry Record Tells You About NCT06008769

The ClinicalTrials.gov registry entry for NCT06008769 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Philadelphia College of Osteopathic Medicine, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which 12 Week Manualized Cognitive-Behavioral Therapy Intervention is the first listed.

NCT06008769 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06008769 about?

NCT06008769 is a clinical study titled "Therapy for People With Opioid Use Disorder". The goal of this pilot clinical trial is to test the feasibility of a 12-week manualized cognitive-behavioral therapy treatment for opioid use disorder in reducing or stopping illicit opioid use in a community setting. Participants will complete 12 weeks of therapy with a behavioral health counselor...

What is the current status of trial NCT06008769?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-08-06. Estimated completion is 2024-08.

What conditions does trial NCT06008769 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT06008769?

The interventions under investigation include: 12 Week Manualized Cognitive-Behavioral Therapy Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06008769?

This trial is sponsored by Philadelphia College of Osteopathic Medicine, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06008769 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.